Publication | Closed Access
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
2.9K
Citations
41
References
2013
Year
ThrombopoiesisThrombosisHematological MalignancyOncologyAntitumor ActivityBlood PlateletMedicineHematologyPharmacotherapySelective Bcl-2 InhibitorPlatelet AntagonistPharmacologyRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
2005 | 3.5K | |
2005 | 3.4K | |
1988 | 3.2K | |
1993 | 3.1K | |
2008 | 1.9K | |
1985 | 1.8K | |
1996 | 1.5K | |
1997 | 1.5K | |
1986 | 1.2K | |
2007 | 1K |
Page 1
Page 1